BioCentury
ARTICLE | Company News

GlaxoSmithKline, UCSD deal

August 17, 2015 7:00 AM UTC

GlaxoSmithKline and the university partnered to treat leukemia and other diseases. The collaboration aims to eliminate cancer stem cell self-renewal by developing a compound to inhibit aberrant RNA ed...